MFDS — authorised 27 August 2012
- Marketing authorisation holder: GILEAD SCIENCES INC
- Status: likely_approved
🇰🇷 Vitekta in South Korea
MFDS authorised Vitekta on 27 August 2012
Marketing authorisation
Vitekta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Vitekta approved in South Korea?
Yes. MFDS authorised it on 27 August 2012.
Who is the marketing authorisation holder for Vitekta in South Korea?
GILEAD SCIENCES INC holds the South Korean marketing authorisation.